Pre-order Enquiry
Request Free Sample
Global Hormonal Contraceptive Market Key Players Competitive Survey Report 2024
SKU ID : ARS-27305177 | Publishing Date : 25-Apr-2024 | No. of pages : 115
Request Sample
Request Customization
Check Discounts
The global Hormonal Contraceptive market size in 2023 is 16600.0 million US dollars, and it is expected to be 22742.1 million US dollars by 2030, with a compound annual growth rate of 4.60% expected in 2024-2030.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Hormonal Contraceptive market include Abbvie, Inc (U.S.), Afaxys, Inc. (U.S.), Merck & Co Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), and Bayer AG (Germany). The share of the top 3 players in the Hormonal Contraceptive market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Hormonal Contraceptive market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Combined Oral Contraceptives accounted for XX% of Hormonal Contraceptive market in 2023. Oral share of XX%.
Androgens accounted for XX% of the Hormonal Contraceptive market in 2023. Estrogens accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Hormonal Contraceptive market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Hormonal Contraceptive market along with global and country-level forecasts from 2024 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Hormonal Contraceptive market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Hormonal Contraceptive market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Hormonal Contraceptive industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
Abbvie, Inc (U.S.)
Afaxys, Inc. (U.S.)
Merck & Co Inc. (U.S.)
Teva Pharmaceuticals Industries Ltd. (Israel)
Bayer AG (Germany)
Pfizer Inc. (U.S.)
Agile Therapeutics (U.S.)
Cupid Ltd. (India)
Helm AG (Germany)
Church & Dwight Co., Inc (U.S.)
Organon group of companies (U.S.)
Reckitt Benckiser Group PLC (U.K.)
Veru Inc. (U.S.)
Boehringer Ingelheim International GmbH (Germany)
Novartis AG (Switzerland)
Lupin (India)
Glenmark Pharmaceuticals (India)
Types list
Combined Oral Contraceptives
Oral
Contraceptives
Implanted Contraceptives
Injected Contraceptives
Intrauterine
Transdermal Patch Vaginal Ring
Application list
Androgens
Estrogens
Progestogens
Antiandrogens
Gonadotropins
Others
MARKET COMPETITIVE LANDSCAPE:
The main players in the Hormonal Contraceptive market include Abbvie, Inc (U.S.), Afaxys, Inc. (U.S.), Merck & Co Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), and Bayer AG (Germany). The share of the top 3 players in the Hormonal Contraceptive market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Hormonal Contraceptive market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Combined Oral Contraceptives accounted for XX% of Hormonal Contraceptive market in 2023. Oral share of XX%.
Androgens accounted for XX% of the Hormonal Contraceptive market in 2023. Estrogens accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Hormonal Contraceptive market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Hormonal Contraceptive market along with global and country-level forecasts from 2024 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Hormonal Contraceptive market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Hormonal Contraceptive market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Hormonal Contraceptive industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
Highlights-Regions
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Player list
Abbvie, Inc (U.S.)
Afaxys, Inc. (U.S.)
Merck & Co Inc. (U.S.)
Teva Pharmaceuticals Industries Ltd. (Israel)
Bayer AG (Germany)
Pfizer Inc. (U.S.)
Agile Therapeutics (U.S.)
Cupid Ltd. (India)
Helm AG (Germany)
Church & Dwight Co., Inc (U.S.)
Organon group of companies (U.S.)
Reckitt Benckiser Group PLC (U.K.)
Veru Inc. (U.S.)
Boehringer Ingelheim International GmbH (Germany)
Novartis AG (Switzerland)
Lupin (India)
Glenmark Pharmaceuticals (India)
Types list
Combined Oral Contraceptives
Oral
Contraceptives
Implanted Contraceptives
Injected Contraceptives
Intrauterine
Transdermal Patch Vaginal Ring
Application list
Androgens
Estrogens
Progestogens
Antiandrogens
Gonadotropins
Others
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
